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2 Abstract: 24 In mammalian females, the transition between quiescent primordial follicles and 25 follicular development is critical for maintaining ovarian function and reproductive 26 longevity. In primary oocytes of mouse quiescent primordial follicles, Golgi complexes 27 are organized into a spherical structure, the Balbiani body. Here, we show that the In adult mammalian females, ovarian function is sustained by primordial follicles, each 48 of which contains a primary oocyte and a single-layer of pregranulosa cells. 49 Coordinated quiescence of primary oocytes and pregranulosa cells is essential for 50 maintaining a pool of dormant primordial follicles, namely the ovarian reserve (1). A 51 cohort of primordial follicles is periodically activated in the adult ovary to produce mature 52 eggs (2). How primordial follicles remain quiescent and then a small cohort initiates 53 development at a certain time remains a mystery. Mouse primary oocytes form by 54 transferring cytoplasm and organelles from sister germ cells (3). In quiescent primary 55 oocytes, the Golgi complexes together with centrosomes coalesce into a spherical 56 structure, the Balbiani body (B-body), a highly conserved, oocyte-specific feature (3, 4) 57 (Fig1.A, B). In zebrafish and Xenopus, the B-body, characterized by the presence of 58 RNA granules and organelle aggregates (mitochondria and Golgi complex), is found in 59 mature unfertilized eggs (4, 5). It plays an essential role in specifying germ cells in the 60 early embryos via RNA storage and translational regulation. In postnatal mouse and 61 human ovaries, the B-body is found only in quiescent primary oocytes, suggesting a 62 potential connection between the B-body and primordial follicle quiescence (6, 7).
64
To understand the nature and function of the mouse B-body, we determined how B-65 body Golgi complexes are organized together with other organelles in primary oocytes. 66 We found that the trans-faces of the Golgi (marked by TNG46) are enclosed in the 67 lumen of the B-body, and the cis-faces (marked by GM130) are exposed to the cytosol 68 (Fig1.C). Electron microscopy (EM) revealed many small vesicles residing inside and 69 4 outside the B-body (Fig1A). We analyzed these vesicles by staining primary oocytes 70 with a COPII antibody, which labels ER-to-Golgi transport vesicles, and with a Clathrin The B-body is only found in quiescent primary oocytes (Fig.1A) . EM images revealed 119 that in the activated oocytes, the spherical structure of the B-body was disassociated 120 ( Fig.2A) . To investigate how the integrity of the B-body is maintained, we examined the 121 distribution of cytoskeleton proteins in quiescent primary oocytes (18, 19) . We found 122 that a-tubulins were highly enriched around the B-body and co-localize with the Golgi 123 cis-face, suggesting a close interaction between microtubules and Golgi cis-face 124 (Fig.2B) . By contrast, stable microtubules, represented by acetylated tubulins, did not (Fig.3B, C) . In cytochalasin D-treated primary oocytes, the 149 Golgi complexes remained linear and clustered, but had lost its spherical structure. In 150 nocodazole-treated primary oocytes, Golgi complexes fragmented into small pieces and 151 dispersed throughout the primary oocyte (Fig.3B ). This result suggests that 152 microtubules and actin may function differently in maintaining B-body integrity. To 153 understand the effect of B-body disassociation, we analyzed ovarian morphology after a 154 6-day culture and a significantly increased number of developing follicles, recognized by 155 the larger volume of their VASA+ oocytes, were observed in drug-treated ovaries 156 (Fig.3D ). On average, 65.2±17.9 developing follicles per ovary were found in control, 157 versus 154.8±11.7 in cytochalasin D-treated ovaries and 124.4±20.5 in nocodazole-158 treated ovaries (Fig.3E ). Similar effects of follicle activation were also observed when 159 we injected cytochalasin D or nocodazole to P4 mice, about two times more developing 160 8 follicles were found in ovaries of injected mice than control mice (Fig.3A, F) . These 
